AUA 2013 - Poster: Safety and changes in laboratory parameters associated with sipuleucel-T in patients with metastatic castration-resistant prostate cancer (mCRPC): Phase 2 ProACT study

SAN DIEGO, CA USA ( - Presented by Thomas Gardner,1 Daniel Petrylak,2 John Corman,3 Simon Hail,4 Ralph Weinstein,5 Robert Sims,6 Todd DeVries,6 and Celestia Higano7 at the American Urological Association (AUA) Annual Meeting - May 4 - 8, 2013 - San Diego Convention Center - San Diego, California USA


Safety and Changes in Lab Parameters Associated with sip-T in Patients with mCRPC thumb


1Urology Indiana University Health, Indianapolis, IN, USA; 2Yale Cancer Center, New Haven, CT, USA; 3Virginia Mason Medical Center, Seattle, WA, USA; 4Mount Sinai School of Medicine, New York, NY, USA; 5US Oncology, Portland, OR, USA; 6Dendreon Corporation, Seattle, WA, USA; 7School of Medicine, University of Washington, Seattle, WA, USA


View Full AUA 2013 Coverage